Drug metabolism in microorganisms | Zendy

Cormac D. Murphy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug metabolism in microorganisms

Author(s) -

Cormac D. Murphy

Publication year - 2014

Publication title -

biotechnology letters

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.548

H-Index - 107

eISSN - 1573-6776

pISSN - 0141-5492

DOI - 10.1007/s10529-014-1653-8

Subject(s) - bacillus megaterium , cytochrome p450 , biology , mutagenesis , drug metabolism , biotransformation , microorganism , biochemistry , bacteria , streptomyces , enzyme , gene , microbiology and biotechnology , genetics , mutant

Several wild type and recombinant microorganisms can transform drugs to the equivalent human metabolites. Fungi, such as Cunninghamella spp., and Streptomyces bacteria express cytochrome P450 (CYP) enzymes that enable analogous phase I (oxidative) reactions with a wide range of drugs. The gene encoding the bifunctional CYP102A1 in Bacillus megaterium can be expressed easily in E. coli, and extensive mutagenesis experiments have generated numerous variants that can produce human drug metabolites. Additionally, human CYP isoforms have been expressed in various hosts. The application of microbial CYPs to the production of human drug metabolites is reviewed, and additional applications in the field of drug development are considered.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research